Kangmei Pharma | 600518 - Ebit

Stock Price
1.90
Daily Change
0.03 1.60%
Monthly
-0.52%
Yearly
-14.03%
Q1 Forecast
1.84

Kangmei Pharma reported CNY-26.7M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Akebia Therapeutics USD 13.51M 27.82M Mar/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Cspc Pharmaceutical CNY 1.22B 60.54M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Genomma Lab Internacional MXN 800.61M 167.16M Dec/2025
Hypermarcas BRL 670.53M 16.64M Sep/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
IQVIA Holdings USD 2.68B 2.1B Dec/2025
Jiangsu Hengrui CNY 1.41B 1.4B Sep/2025
Kangmei Pharma CNY -26.7M 43.13M Sep/2025
Moderna USD -857M 597M Dec/2025
Organon & Co USD 388M 28M Sep/2025
Revvity USD 145.83M 47.49M Dec/2025
Sh Fosun Pharma CNY 691.16M 985.91M Jun/2025
Tectonic Therapeutic USD -22.33M 4.03M Jun/2025
Viatris USD -157.5M 392M Dec/2025
Wuxi Apptec CNY 4.6B 822.25M Sep/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025
Zz Pientze Pharmaceu CNY 501.33M 15.6M Sep/2025